Sort
16,179 grants matching “malaria”
CK25-035 Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya
$300,000Feiko Olaf Ter Kuile · Tmliverpool School Of Tropical Medicine · U01 · FY2025 · CK
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
$300,000Virginia Commonwealth University · R01 · FY2003 · AI
GH12-004, S. Africa: GDD Public Health Research
$300,000Natalie Mayet · National Health Laboratory Service · U19 · FY2016 · GH
Genetically Attenuated Malaria Sporozote Vaccine
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2007 · AI
Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development
$300,000Douglas E. Brough · Genvec, Inc. · R43 · FY2013 · AI
A cloud-based system for scalable, privacy-preserving, and interactive immune repertoire analysis in vaccination and infection
$300,000Jun Xiao · Immudx, Llc · R43 · FY2018 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug
$300,000David H Peyton · Designmedix, Inc. · R41 · FY2011 · AI
Development of an ELISA for serosurveillance of human hookworm
$300,000Andrew E. Levin · Kephera Diagnostics, Llc · R43 · FY2024 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites (PvSPZ Challenge) for controlled human malaria infection (CHMI)
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2016 · AI
Host and Microbial Genetic Determinants of Febrile Illness in West Africa
$300,000Christian T. Happi · Redeemer'S University · U01 · FY2016 · HG
SUPPORTING THE IMPLEMENTATION OF MALARIA PREVENTION AND CONTROL STRATEGIES AND RE
$300,000Matthew G Dorsey · University Of California, San Francisco · U51 · FY2011 · CK
The development of a novel antifungal for drug resistance
$300,000Esteban Edward Mena · Lifepharms, Inc. · R43 · FY2025 · AI
Development of an ELISA for serosurveillance of human hookworm
$300,000Andrew E. Levin · Kephera Diagnostics, Llc · R43 · FY2023 · AI
Multi-ligand merozoite invasion blocking malaria vaccine
$300,000B. Kim Lee Sim · Protein Potential, Llc · R43 · FY2012 · AI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
Multi-stage multi-antigen Vaccine for interrupting Malaria Transmission
$300,000B. Kim Lee Sim · Protein Potential, Llc · R43 · FY2013 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage.
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2021 · AI
Aseptic, purified attenuated sporozite malaria vaccine
$300,000Sanaria, Inc. · R43 · FY2005 · AI
Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development
$300,000Joseph T Bruder · Genvec, Inc. · R43 · FY2012 · AI
Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines
$300,000Peter F. Billingsley · Sanaria, Inc. · R43 · FY2023 · AI
Attenuation of Liquid Formulation for PfSPZ Vaccine by X-Ray
$300,000Eric R James · Sanaria, Inc. · R43 · FY2021 · AI
Ultracompact sample-to-answer nucleic acid test on USB stick
$300,000Weihua Guan · Pennsylvania State Univ University Park · · FY2019 · ENG
Facile Detection of Soil-Transmitted Helminth Infections
$300,000Michael J Crawford · Monsanto Company · R43 · FY2011 · AI
Adenovirus-vectored RSV vaccine not inhibited by maternal immunity
$300,000Jason Graham Gall · Genvec, Inc. · R43 · FY2012 · AI
Collaborative Research: Production of known and novel, safe, and biodegradable pyrethrin-type insecticides in tomato
$300,000Eran Pichersky · Regents Of The University Of Michigan - Ann Arbor · · FY2016 · ENG